勃林格殷格翰的思力华多少钱？

(Repimat) is one of the blockbuster products of Boehringer Ingelheim. It is suitable for the maintenance treatment of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, the maintenance treatment of associated dyspnea and the prevention of acute exacerbations. The drug was launched globally in 2002 and landed in China in 2006. The Respimat device was launched globally in 2007. The successful launch of this drug has also provided great help for the treatment of many patients. So, how much does Boehringer Ingelheim’s Spliva cost?

It is understood that the prices of drugs on sale in China are relatively expensive. Although they are currently included in medical insurance, many patients who require long-term treatment still hope to obtain more cost-effective drugs through other drug purchase channels. Overseas, the current price of Siliva is as low as 170$ per box. Patients in need can contact Medical Companion Travel to obtain their specific drug purchasing channels. Of course, if financial conditions permit, patients can also go abroad to purchase medicines on their own.

In recent years, many hospitals have conducted clinical application research on the clinical application of tiotropium bromide in the treatment of chronic obstructive pulmonary disease. It is believed that Silihua can become one of the ideal drugs for the current clinical treatment of patients with moderate to severe stable COPD. There are also studies showing that tiotropium bromide can significantly reduce airflow limitation, help to close refractory pneumothorax, significantly improve mobility and quality of life, and conclude that inhaled tiotropium bromide dry powder shows good efficacy and compliance in patients with severe COPD, and that its efficacy is related to age and compliance.

Boehringer Ingelheim is currently the largest and most successful privately held pharmaceutical group in the world. Boehringer Ingelheim has footprints all over the world. Boehringer Ingelheim has launched many well-known drugs, invested heavily in respiratory, central nervous system, gastrointestinal tract, cardiovascular and cerebrovascular and other fields and created many excellent products, including.

Recommended hot articles: /newsDetail/92327.html